CM
VC

Catalio Capital Management

Catalio Capital Management has 8 investments tracked. The firm invests across various stages and sectors. Investment data includes stage, sector, and investment date. Track Catalio Capital Management's investment history and portfolio companies. Analyze their investment strategies.

113
Investments Tracked

About Catalio Capital Management

Catalio Capital Management is a venture capital firm based in the United States. Brouky tracks 113 investments associated with the firm.

Catalio Capital Management invests across Healthcare & Life Sciences; Consumer, Lifestyle & Services; Industry & Hardware and Pharmaceutical Development. Coverage extends to 8 sectors in total. Participation spans Series A, Series B and Series C+ rounds.

Catalio Capital Management invests in biomedical technology companies. They focus on early-stage ventures with the potential to transform healthcare.

Investment Focus

Stage Focus
series-aseries-bseries-c-plus
Sectors
Healthcare & Life SciencesConsumer, Lifestyle & ServicesIndustry & Hardwarepharmaceutical-developmentmedical devicesreviewsnewsneurology

Investment Thesis

Catalio Capital Management invests in biomedical technology companies. They focus on early-stage ventures with the potential to transform healthcare.

Catalio Capital Management Portfolio Companies

24 of 60 tracked holdings.

Portfolio outcomes
61 active7 acquired8.0% exit rate

Team

George C. PetrocheilosCo-Founder & Managing Partner
R. Jacob VogelsteinCo-Founder & Managing Partner
Constantine AlexosAnalyst
Brianna BednarAssociate, Accounting
Brian BrennanGeneral Counsel
Tom BrooksPartner
Pasquale ChiacchiariPrincipal & Head of Data Science
Christopher ContiSenior Associate, Accounting
Jessica CordobaAdministrative Assistant
Timmy DavisSenior Advisor
Will DenehyVice President – Europe
Sharon D’SouzaSenior Advisor

Explore Catalio Capital Management's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Consumer, Lifestyle & Services